JH-001 (Bivision)

N/A

Report date: 2025/03/07 20:00:40
NME

Base Information

Drug NameJH-001 (Bivision)
Drug Alias NameJH-001 (Bivision)
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionDiagnostic imaging enhancers
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBivision Biomedical Technology (Nanjing) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBivision Biomedical Technology (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A